News

Videos from the Pompe community illustrating how strength and resilience are gained through friendship.

Amicus Therapeutics announces that the European Commission (EC) has granted approval for Opfolda® (miglustat), an enzyme stabilizer of cipaglucosidase alfa, an...

The IPA is excited to announce its plans for International Pompe Day. This year, we are focusing on raising awareness...

Over the last 2 years, it is clear that the COVID-19 pandemic has had wide reaching effects on people all...

Author: Maryze Schoneveld van der Linde, Volunteer, Communications Coordinator, International Pompe Association Date: March 19, 2022 On February 24, 2022, at...

One common challenge that all potential future therapies will face is how to best design trials in an ultra-raredisease with...

This year’s theme is “Pompe Around the World.” No matter where we live we are all connected.

PHILADELPHIA, Feb. 11, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics, a patient-dedicated global biotechnology company focused on discovering, developing and delivering...